HealthDay - TUESDAY, July 17 (HealthDay News) -- Taking a pricey breastcancer drug called lapatinib (Tykerb) with food rather than on an emptystomach may improve its absorption by the body -- lowering the dosesneeded and greatly cutting costs for patients, a new study shows.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.